[EN] THERAPEUTICS AGAINST PATHOGENIC CORONAVIRUSES<br/>[FR] AGENTS THÉRAPEUTIQUES DIRIGÉS CONTRE LES CORONAVIRUS PATHOGÈNES
申请人:[en]THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
公开号:WO2022115327A1
公开(公告)日:2022-06-02
Compounds for use in treating a coronavirus infection in a subject, particularly an infection caused by SARS-CoV-2, SARS-CoV or MER-CoV.